Applications

1348 – Transcatheter closure of ventricular septal defect

Find out about the service or technology in this application and the medical condition it addresses. You can also view the application documents, the deadlines for providing consultation input and the outcome of the application when the MSAC process is complete.

  • Status Complete
  • Type New application
  • Pre-PASC consultation -
  • Pre-MSAC consultation -
  • Outcome Supported

Application details

Reason for application

New MBS item.

Service or technology in this application

Transcatheter closure of a ventricular septal defect is performed under general anesthesia and access is obtained utilizing both femoral artery and femoral vein. Ventricular angiography would demonstrate the anatomy of the ventricular septal defect prior to closure. The ventricular septal defect is crossed using a catheter from the left ventricular side and a device is deployed which will result in complete occlusion of the ventricular septal defect.

Type: Therapeutic

Medical condition this application addresses

A ventricular septal defect (VSD) is a hole in the ventricular septum between the left ventricle and the right ventricle. The two types of ventricular septal defects suitable for closure are the perimembranous VSD which is situated high in the ventricular septum beneath the aortic valve and muscular VSD which can be located anywhere in the ventricular septum. The presence of a VSD results in a left to right shunt and consequent volume overload of the heart. This can result in cardiac failure. The usual indication for closure of VSD would be a net shunt greater than 1.6:1.

Meetings to consider this application

  • PASC meeting: 18 April 2013
  • ESC meeting: 10 to 11 October 2013
  • MSAC meeting: 28 to 29 November 2013